[1] SIPE J D,BENSON M D,BUXBAUM J N,et al.Amyloid fibril proteins and amyloidosis:chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines[J].Amyloid,2016,23(4):209-213.
[2] van ALLEN M W,FROHLICH J A,DAVIS J R.Inherited predisposition to generalized amyloidosis.Clinical and pathological study of a family with neuropathy,nephropathy,and peptic ulcer[J].Neurology,1969,19(1):10-25.
[3] ANDEEN N K,LAM D Y,de BOER I H,et al.Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation[J].J Am Soc Nephrol,2014,25(12):2703-2705.
[4] ROWCZENIO D,DOGAN A,THEIS J D,et al.Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-Ⅰ[J].Am J Pathol,2011,179(4):1978-1987.
[5] 梁少珊,范文静,葛永纯,等.遗传性载脂蛋白A-Ⅰ型淀粉样变性[J].肾脏病与透析肾移植杂志,2015,24(3):289-293.
[6] SOUTAR A K,HAWKINS P N,VIGUSHIN D M,et al.Apolipoprotein AⅠ mutation Arg-60 causes autosomal dominant amyloidosis[J].Proc Natl Acad Sci U S A,1992,89(16):7389-7393.
[7] BOOTH D R,TAN S Y,BOOTH S E,et al.Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AⅠ gene[J].J Clin Invest,1996,97(12):2714-2721.
[8] MURPHY C L,WANG S,WEAVER K,et al.Renal apolipoprotein A-Ⅰ amyloidosis associated with a novel mutant Leu64Pro[J].Am J Kidney Dis,2004,44(6):1103-1109.
[9] PERSEY M R,BOOTH D R,BOOTH S E,et al.Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-Ⅰ[J].Kidney Int,1998,53(2):276-281.
[10] ERIKSSON M,SCHÖNLAND S,YUMLU S,et al.Hereditary apolipoprotein AⅠ-associated amyloidosis in surgical pathology specimens:identification of three novel mutations in the APOA1 gene[J].J Mol Diagn,2009,11(3):257-262.
[11] GREGORINI G,IZZI C,RAVANI P,et al.Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-Ⅰ amyloidosis[J].Kidney Int,2015,87(6):1223-1229.
[12] HAMIDI A L,LIEPNIEKS J J,HAMIDI A K,et al.Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1[J].Am J Pathol,1999,154(1):221-227.
[13] AMARZGUIOUI M,MUCCHIANO G,HÄGGQVIST B,et al.Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation[J].Biochem Biophys Res Commun,1998,242(3):534-539.
[14] VONBERG F W,GILBERTSON J A,ROWCZENIO D,et al.Amyloid cardiomyopathy associated with a novel apolipoprotein A-Ⅰ Q172P variant[J].Amyloid,2015,22(4):252-253.
[15] HAMIDI A K,LIEPNIEKS J J,NAKAMURA M,et al.A novel apolipoprotein A-1 variant,Arg173Pro,associated with cardiac and cutaneous amyloidosis[J].Biochem Biophys Res Commun,1999,257(2):584-588.
[16] OBICI L,BELLOTTI V,MANGIONE P,et al.The new apolipoprotein A-Ⅰ variant leu(174)→Ser causes hereditary cardiac amyloidosis,and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide[J].Am J Pathol,1999,155(3):695-702.
[17] de SOUSA M M,VITAL C,OSTLER D,et al.Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAⅠ Leu178His amyloidosis[J].Am J Pathol,2000,156(6):1911-1917.
[18] RÖCKEN C,TAUTENHAHN J,BVHLING F,et al.Prevalence and pathology of amyloid in atherosclerotic arteries[J].Arterioscler Thromb Vasc Biol,2006,26(3):676-677.
[19] SOLOMON A,MURPHY C L,KESTLER D,et al.Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-Ⅰ[J].Arthritis Rheum,2006,54(11):3545-3550.
[20] LOAVENBRUCK A J,CHAUDHRY V,ZELDENRUST S R,et al.Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma[J].Muscle Nerve,2012,46(5):817-822.
[21] PINNEY J H,HAWKINS P N.Amyloidosis[J].Ann Clin Biochem,2012,49(Pt 3):229-241.
[22] GILLMORE J D,STANGOU A J,LACHMANN H J,et al.Organ transplantation in hereditary apolipoprotein AⅠ amyloidosis[J].Am J Transplant,2006,6(10):2342-2347.
[23] RICHARDS D B,COOKSON L M,BERGES A C,et al.Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component[J].N Engl J Med,2015,373(12):1106-1114.
[24] OBICI L,FRANCESCHINI G,CALABRESI L,et al.Structure,function and amyloidogenic propensity of apolipoprotein A-Ⅰ[J].Amyloid,2006,13(4):191-205.
[25] 商丹,赵艳芳.载脂蛋白A-1心血管保护作用的认识[J].现代医学,2011,39(5):615-618.
[26] GURSKY O,MEI X,ATKINSON D.The crystal structure of the C-terminal truncated apolipoprotein A-Ⅰ sheds new light on amyloid formation by the N-terminal fragment[J].Biochemistry,2012,51(1):10-18.
[27] DAS M,MEI X,JAYARAMAN S,et al.Amyloidogenic mutations in human apolipoprotein A-Ⅰ are not necessarily destabilizing-a common mechanism of apolipoprotein A-Ⅰ misfolding in familial amyloidosis and atherosclerosis[J].FEBS J,2014,281(11):2525-2542.
[28] SAID S M,SETHI S,VALERI A M,et al.Renal amyloidosis:origin and clinicopathologic correlations of 474 recent cases[J].Clin J Am Soc Nephrol,2013,8(9):1515-1523. |
